Today's Low
₹ 540.25
Today's High
₹ 554.95
52 Weeks Low
₹ 350.45
52 Weeks High
₹ 592.60
Lower
₹ 444.40
Upper
₹ 666.50
Jubilant Ingrevia Limited provides life science products and solutions in India and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Life Science Chemicals. The Specialty Chemicals segment offers specialty ingredients, fine chemicals, crop protection chemicals, and custom development and manufacturing services. The Nutrition & Health Solutions segment provides nutrition and health ingredients, animal nutrition and health solutions, and human nutrition and health solutions. The Life Science Chemicals offers life science ingredients and specialty ethanol. The company also offers pyridine and picolines, cyanopyridines, piperidines, acetyl pyridines, amino pyridines, halo pyridines, pyridine aldehydes, metal complexes, amino pyridines, halogenated pyridines, quaternary salts, alkyl pyridines, vitamin B3 and picolinates, riboflavin phosphate sodium, nutritional premixes, antioxidants, straight ingredients, acetic anhydride, acetic acid, ethyl acetate, propionic anhydride, absolute alcohol, ethanol, biocompost, CO2 and ETO mixtures. In addition, it provides route design, process development, process optimization, and scale-up and commercial manufacturing of intermediates. Further, the company offers vitamins, mineral premixes, stress regulator, amino acid, herbal choline, herbal non-antibiotic growth promoter and egg quality enhancer, toxin binder, acidifiers, and enzymes and emulsifiers. It serves pharmaceutical, nutrition, agrochemical, consumer, and industrial customers. The company was formerly known as Jubilant LSI Limited and changed its name to Jubilant Ingrevia Limited in October 2020. Jubilant Ingrevia Limited was incorporated in 2019 and is based in Noida, India.
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|
Total Current Assets | 1,818.0 | 1,764.6 | 1,423.6 | 0.1 |
Total Non-Current Assets | 2,431.0 | 2,017.7 | 1,942.5 | 0.0 |
Total Assets | 4,249.0 | 3,782.2 | 3,366.1 | 0.1 |
Total Current Liabilities | 1,179.6 | 1,052.8 | 894.3 | 0.2 |
Total Non-Current Liabilities | 403.2 | 296.3 | 548.9 | 0.0 |
Shareholder's Funds | 2,666.2 | 2,433.1 | 1,922.9 | -0.1 |
Total Liabilities | 4,249.0 | 3,782.2 | 3,366.1 | 0.1 |
The Industry Price to BV stands at 10.52, vs the Price to BV of 3.13, which results in a Negative aspect.
The Industry Quick Ratio stands at 1.33, vs the Quick Ratio of 0.30, which results in a Negative aspect.
The Industry Current Ratio stands at 1.94, vs the Current Ratio of 0.30, which results in a Negative aspect.
The Industry Debt to Equity Ratio stands at 0.86, vs the Debt to Equity Ratio of 0.00, which results in a Positive aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|
Total Income | 4,772.7 | 4,949.4 | 684.1 | 0.0 |
Total Expenditure | 4,225.6 | 4,117.5 | 567.0 | 0.2 |
Operating Profit(Excl OI) | 580.5 | 863.3 | 119.7 | -0.2 |
Add: Other Income | 33.4 | 31.5 | 2.6 | 0.0 |
Operating Profit | 580.5 | 863.3 | 119.7 | -0.2 |
Less: Interest | 21.6 | 30.9 | 7.3 | 0.0 |
PBDT | 558.9 | 832.4 | 112.4 | -0.2 |
Less: Depreciation Amortization | 122.2 | 123.4 | 22.1 | 0.0 |
PBT & Exceptional Items | 436.8 | 709.0 | 90.3 | -0.2 |
Less: Exceptional Income Expenses | 0.0 | 0.0 | -12.9 | 0.0 |
Profit Before Tax | 436.7 | 708.9 | 77.4 | -0.2 |
Less: Taxation | 129.2 | 232.2 | 23.0 | 0.0 |
Profit After Tax | 307.5 | 476.7 | 54.4 | -0.2 |
Earnings Per Share | 1.9 | 3.0 | 0.3 | -0.3 |
The Industry PAT Growth stands at 40.87, vs the PAT Growth of 0.00, which results in a Negative aspect.
The Industry PAT Margin stands at 13.09, vs the PAT Margin of 0.00, which results in a Negative aspect.
The Industry Dividend Yield stands at 0.43, vs the Dividend Yield of 0.93, which results in a Positive aspect.
The Industry PE Ratio stands at 58.70, vs the PE Ratio of 41.61, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|
Profit Before Tax | 436.7 | 708.9 | 77.4 | -0.2 |
Tax Paid | -77.4 | -128.1 | -11.5 | 0.0 |
Adjustment | 148.3 | 174.3 | 45.4 | 0.0 |
Changes In Working Capital | 436.7 | 708.9 | 77.4 | -0.2 |
Cash Flow after changes in Working Capital | 539.8 | 580.8 | 123.8 | 0.0 |
Cash Flow from Operating Activities | 462.5 | 452.7 | 112.3 | 0.0 |
Cash Flow from Investing Activities | -471.9 | -71.9 | -43.7 | 0.0 |
Cash Flow from Financing Activities | 41.6 | -417.8 | -72.4 | 0.1 |
Net Cash Inflow / Outflow | 32.2 | -36.9 | -3.7 | 0.1 |
Opening Cash & Cash Equivalents | 37.6 | 73.3 | 0.1 | 0.0 |
Closing Cash & Cash Equivalent | 72.7 | 37.6 | 73.3 | 0.1 |
The Industry PCF RATIO stands at 47.24, vs the PCF RATIO of 0.00, which results in a Negative aspect.
The Industry PFCF Ratio stands at 8.64, vs the PFCF Ratio of 0.00, which results in a Negative aspect.
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 9,664.0 | 10,199.4 | 10,750.2 | 11,449.8 | 11,583.1 | 13,035.8 | 11,658.2 | 12,957.5 | 12,864.8 | 12,225.7 | 11,445.6 | 6,841.3 |
Total Income | 9,751.8 | 10,284.6 | 10,835.2 | 11,539.8 | 11,653.1 | 13,108.7 | 11,759.0 | 13,049.4 | 12,958.4 | 12,295.3 | 11,505.4 | 6,867.3 |
Total Expenditure | 8,708.3 | 9,022.8 | 9,583.7 | 10,429.3 | 10,070.1 | 11,506.7 | 10,249.4 | 11,533.8 | 10,738.5 | 10,272.5 | 8,630.5 | 5,670.1 |
PBIDT (Excl OI) | 955.7 | 1,176.6 | 1,166.5 | 1,020.5 | 1,513.0 | 1,529.1 | 1,408.8 | 1,423.7 | 2,126.3 | 1,953.2 | 2,815.1 | 1,171.2 |
Other Income | 87.8 | 85.2 | 85.0 | 90.0 | 70.0 | 72.9 | 100.8 | 91.9 | 93.6 | 69.6 | 59.8 | 26.0 |
Operating Profit | 1,043.5 | 1,261.8 | 1,251.5 | 1,110.5 | 1,583.0 | 1,602.0 | 1,509.6 | 1,515.6 | 2,219.9 | 2,022.8 | 2,874.9 | 1,197.2 |
Interest | 150.6 | 125.2 | 114.6 | 57.0 | 66.9 | 51.0 | 40.9 | 61.2 | 48.5 | 71.6 | 128.1 | 73.3 |
Exceptional Items | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -129.4 |
PBDT | 892.9 | 1,136.6 | 1,136.9 | 1,053.5 | 1,516.1 | 1,551.0 | 1,468.7 | 1,454.4 | 2,171.4 | 1,951.2 | 2,746.8 | 994.5 |
Depreciation | 342.4 | 339.1 | 323.0 | 298.4 | 300.0 | 309.8 | 313.6 | 309.2 | 302.6 | 305.9 | 316.2 | 220.6 |
Profit Before Tax | 550.5 | 797.5 | 813.9 | 755.1 | 1,216.1 | 1,241.2 | 1,155.1 | 1,145.2 | 1,868.8 | 1,645.3 | 2,430.6 | 773.9 |
Tax | 165.2 | 223.8 | 237.2 | 232.1 | 300.7 | 398.0 | 361.3 | 459.2 | 578.0 | 537.2 | 747.9 | 230.3 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | 385.3 | 573.7 | 576.7 | 523.0 | 915.4 | 843.2 | 793.8 | 686.0 | 1,290.8 | 1,108.1 | 1,682.7 | 543.6 |
Net Profit | 385.3 | 573.7 | 576.7 | 523.0 | 915.4 | 843.2 | 793.8 | 686.0 | 1,290.8 | 1,108.1 | 1,682.7 | 543.6 |
ADDITIONAL INFOS: | ||||||||||||
Equity Capital | 158.0 | 158.0 | 158.0 | 159.0 | 159.0 | 159.0 | 159.0 | 159.0 | 159.0 | 159.0 | 159.0 | 159.3 |
Reserves | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EPS | 2.4 | 3.6 | 3.6 | 3.3 | 5.8 | 5.3 | 5.0 | 4.3 | 8.1 | 7.0 | 10.6 | 5.2 |
Operating Profit Margin | 10.8 | 12.4 | 11.6 | 9.7 | 13.7 | 12.3 | 12.9 | 11.7 | 17.3 | 16.5 | 25.1 | 17.5 |
Net Profit Margin | 4.0 | 5.6 | 5.4 | 4.6 | 7.9 | 6.5 | 6.8 | 5.3 | 10.0 | 9.1 | 14.7 | 7.9 |
The Industry Mcap Growth stands at 41.85, vs the Mcap Growth of 0.00, which results in a Negative aspect.
The Industry Net Sales Growth stands at 22.94, vs the Net Sales Growth of 0.00, which results in a Negative aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 609.75 | 642.79 | 557.62 |
R3 | 589.83 | 591.78 | 547.74 |
R2 | 569.92 | 570.89 | 544.44 |
R1 | 553.88 | 555.83 | 541.15 |
Pivot | 533.97 | 534.94 | 533.97 |
S1 | 517.93 | 519.88 | 534.55 |
S2 | 498.02 | 498.99 | 531.26 |
S3 | 481.98 | 483.93 | 527.96 |
S4 | 465.95 | 427.09 | 518.08 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
77.40
Neutral
RSI
67.15
Neutral
ROC
17.63
Bullish
UltimateOscillator
51.72
Neutral
Williams Indicator
-23.76
Neutral
CCI Indicator
104.41
Bearish
MACD
-2,552.04
Bearish
Stochastic Indicator
72.05
Neutral
ATR
25.83
High Volatility
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|---|---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|---|---|---|
09-02-2024 | 2.50 | 250 | Interim |
10-08-2023 | 2.50 | 250 | Final |
10-02-2023 | 2.50 | 250 | Interim |
23-08-2022 | 2.50 | 250 | Final |
10-02-2022 | 2.50 | 250 | Interim |
05-08-2021 | 0.35 | 35 | Final |
Date Of Conduct | Board Meeting Details |
---|---|
30-01-2024 | Quarterly Results & Interim Dividend |
01-11-2023 | Quarterly Results |
18-08-2023 | Inter-alia, to consider a proposal for raising of funds through Commercial Papers. |
26-07-2023 | Quarterly Results |
16-05-2023 | Jubilant Ingrevia Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2023 ,inter alia, to consider and approveIn terms of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'ListingRegulations'), we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, May 16, 2023, to inter-aliaconsider: 1. Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2023; and 2. Recommendation ofFinal Dividend for the Financial Year ended March 31, 2023, if any. |
31-01-2023 | Quarterly Results & Interim Dividend |
20-10-2022 | Quarterly Results |
05-08-2022 | Quarterly Results |
17-05-2022 | Final Dividend & Audited Results |
13-05-2022 | Inter alia, to consider change in Terms and Conditions including early redemption/ buyback of 1,000 7.90% Secured, Rated, Listed, Redeemable NonConvertible Debentures of Rs. 10,00,000 (Rupees Ten Lac) each aggregating to Rs. 100 Crore |
01-02-2022 | Quarterly Results & Interim Dividend |
02-12-2021 | Inter alia, to consider buy-back of 1,000 7.90% Secured, Rated, Listed, Redeemable Non- Convertible Debentures of Rs. 10,00,000 (Rupees Ten Lac) each aggregating to Rs. 100 Crore. |
19-10-2021 | Quarterly Results |
20-07-2021 | Quarterly Results |
07-06-2021 | Dividend & Audited Results |